CMS’s 2026 OPPS final rule updates outpatient payment policies, adjusts 340B drug recoupment, extends site-neutral payment models, expands ASC services, and enhances hospital price transparency requirements effective January 2026.

CMS unveils the GENERous Medicaid payment model introducing MFN drug pricing, alongside expanded Trump administration drug pricing agreements and key regulatory updates for 2026.

Study finds the 340B Drug Pricing Program contributes to higher Affordable Care Act Silver Plan premiums, affecting insurance costs and subsidies.

Summary of Trump's executive order directing HHS to reduce prescription drug costs, focusing on Medicare reimbursement for 340B drugs, IRA drug pricing provisions, and CMS premium stabilization efforts.